Literature DB >> 24174585

Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.

Harry Alexopoulos1, Sofia Akrivou, Marinos C Dalakas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24174585     DOI： 10.1212/01.wnl.0000436617.40779.65

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  14 in total

1.  Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.

Authors:  Eleni E Magira; Harry Alexopoulos; Evangelos Charitatos; Dimitris Michas; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

2.  A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.

Authors:  Marinos C Dalakas; Goran Rakocevic; James M Dambrosia; Harry Alexopoulos; Beverly McElroy
Journal:  Ann Neurol       Date:  2017-08-09       Impact factor: 10.422

3.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

4.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors:  Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

Review 5.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

6.  Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.

Authors:  Nuria Gresa-Arribas; Helena Ariño; Eugenia Martínez-Hernández; Mar Petit-Pedrol; Lidia Sabater; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

7.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Authors:  Alexander Carvajal-González; M Isabel Leite; Patrick Waters; Mark Woodhall; Ester Coutinho; Bettina Balint; Bethan Lang; Philippa Pettingill; Aisling Carr; Una-Marie Sheerin; Rayomand Press; Raomand Press; Michael P Lunn; Ming Lim; Paul Maddison; H-M Meinck; Wim Vandenberghe; Angela Vincent
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

Review 8.  Spinal-generated movement disorders: a clinical review.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2015-12-24

9.  Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Authors:  Eugenia Martinez-Hernandez; Helena Ariño; Andrew McKeon; Takahiro Iizuka; Maarten J Titulaer; Mateus M Simabukuro; Eric Lancaster; Mar Petit-Pedrol; Jesús Planagumà; Yolanda Blanco; Robert J Harvey; Albert Saiz; Francesc Graus; Josep Dalmau
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 10.  Autoimmune Neurogenic Dysphagia.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Dysphagia       Date:  2021-07-05       Impact factor: 2.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.